Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial
2010
Hallmarks of Cancer: The Next Generation
2011 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment
2009
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature
2003
Optimal Management of the T1G3 Bladder Cancer
2005
Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review
2018
Cranberry Juice Fails to Prevent Recurrent Urinary Tract Infection: Results From a Randomized Placebo-Controlled Trial
2010
Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement
2008
The epidemiology of urinary tract infection
2010 Standout
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
2006 Standout
Re: Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men With or Without Erectile Dysfunction
2010
Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men With or Without Erectile Dysfunction
2010
Cranberries for preventing urinary tract infections
2004
Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study
2005
Guidelines on Bladder Cancer
2002
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy
2015
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays
2005
Imaging angiogenesis of genitourinary tumors
2010
Urinary Tract Infection and Bacteriuria in Pregnancy
2015
Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy
2011
Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2011
Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)
2013
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
Biofilms: an emergent form of bacterial life
2016 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Urothelial Carcinoma of the Prostate
2007
Update in Adult Urinary Tract Infection
2011
Population‐based comparative effectiveness of nephron‐sparing surgery vs ablation for small renal masses
2012
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C
2007
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
2012
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
2016
Renal Cell Carcinoma: Dynamic Contrast-enhanced MR Imaging for Differentiation of Tumor Subtypes—Correlation with Pathologic Findings
2009
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Uncomplicated Urinary Tract Infection in Adults Including Uncomplicated Pyelonephritis
2007
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea. Estudio nacional multicéntrico
2008
A systematic review of intravesical bacillus Calmette‐Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Sexual dysfunction in the elderly: age or disease?
2005
Bipolar Plasma Vaporization vs Monopolar and Bipolar TURP–A Prospective, Randomized, Long-term Comparison
2011
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Health-related quality of life associated with lower urinary tract symptoms in four countries
1998
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Uncomplicated Urinary Tract Infection
2012 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Gatifloxacin 400mg as a single shot or 200mg once daily for 3 days is as effective as ciprofloxacin 250mg twice daily for the treatment of patients with uncomplicated urinary tract infections
2004
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions
2007
Rhabdomyolysis: A review
2002
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review
2008
Renal cell carcinoma
2017 Standout
Risk Assessment of Prostatic Pathology in Patients Undergoing Radical Cystoprostatectomy
2007
Motor recovery after stroke: a systematic review
2009 Standout
Mechanism of Quinolone Action and Resistance
2014 Standout
Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7)
2003
Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours
2012
Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
2002
Contemporary Management of Uncomplicated Urinary Tract Infections
2008
Bipolar transurethral resection of the prostate ‐ technical modifications and early clinical experience
2007
Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review
2017
HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
2005
THE PREDICTIVE VALUE OF MUSCULARIS MUCOSAE INVASION AND p53 OVER EXPRESSION ON PROGRESSION OF STAGE T1 BLADDER CARCINOMA
2001
Immunization with the Yersiniabactin Receptor, FyuA, Protects against Pyelonephritis in a Murine Model of Urinary Tract Infection
2013
FUNCTIONAL RESULTS OF ORTHOTOPIC ILEAL NEOBLADDER WITH SEROUS-LINED EXTRAMURAL URETERAL REIMPLANTATION: EXPERIENCE WITH 450 PATIENTS
2001
The Value of Preoperative Needle Core Biopsy for Diagnosing Benign Lesions Among Small, Incidentally Detected Renal Masses
2008
Percutaneous Biopsy of Primary Tumor in Metastatic Renal Cell Carcinoma to Predict High Risk Pathological Features: Comparison With Nephrectomy Assessment
2010
Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition
2013
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Bladder Cancer
2020 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Inhibition of the tonic contraction in the treatment of erectile dysfunction
2003
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDY
2001
Serum-migration inhibitory activity in patients with sarcoidosis
1979 StandoutNobel
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Initial Tumor Stage and Grade as a Predictive Factor for Recurrence in Patients With Stage T1 Grade 3 Bladder Cancer
2004
URINARY INCONTINENCE AND LOWER URINARY TRACT SYMPTOMS: AN EPIDEMIOLOGICAL STUDY OF MEN AGED 45 TO 99 YEARS
1997
Cancer treatment and survivorship statistics, 2016
2016 Standout
Physiologic and pathologic manifestations of lymphokine action
1986 StandoutNobel
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Renal Tumor Biopsies for Evaluation of Small Renal Tumors: Why, in Whom, and How?
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2015
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Contemporary Results of Percutaneous Biopsy of 100 Small Renal Masses: A Single Center Experience
2008
Antimicrobial Agents in Transurethral Prostatic Resection
1987
Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study
2008
Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis
2008
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections
2013
Systematic review of the oncological and functional outcomes of pelvic organ‐preserving radical cystectomy ( RC ) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer
2017
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
URETHRAL TUMOR RECURRENCE FOLLOWING CYSTECTOMY AND URINARY DIVERSION: CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN 768 MALE PATIENTS
2005
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Henry Botto being referenced
EAU Guidelines for the Management of Urinary and Male Genital Tract Infectionstextsuperscript1
2001
Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study
2010
After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?
2002
Heat shock proteins HSP27, HSP60, HSP70, and HSP90
2003
The relationship between sexual life and urinary condition in the French community
1996
Incidence and Risk Factors of Bacteriuria after Transurethral Resection of the Prostate
2001
In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules
2008
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections
2009
The Z‐shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients
2011
Impact of Symptoms of Prostatism on Level of Bother and Quality of Life of Men in the French Community
1995
Prognostic Value of MIB–1 Antibody Labeling Index to Predict Response to Bacillus Calmette–Guérin Therapy in a High–Risk Selected Population of Patients with Stage T1 Grade G3 Bladder Cancer
2000
Myopathie hypothyroïdienne : à propos d'un cas avec élévation majeure de la créatine phosphokinase, myoglobinémie et insuffisance rénale transitoire
1990
French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy
2012
EAU Guidelines for the Management of Urinary and Male Genital Tract Infections<sup>1</sup>
2001
Efficacy and Safety of a Novel Combination of L-Arginine Glutamate and Yohimbine Hydrochloride: A New Oral Therapy for Erectile Dysfunction
2002
Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system
2011
Should Bladder Biopsies be Performed Routinely after Bacillus Calmette-Guérin Treatment for High-Risk Superficial Transitional Cell Cancer of the Bladder?
2006
Long-Term Women-Reported Quality of Life After Radical Cystectomy and Orthotopic Ileal Neobladder Reconstruction
2013
Low-Dose BCG Instillations in the Treatment of Stage T1 Grade 3 Bladder Tumours: Recurrence, Progression and Success
1998
Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy
2008
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology
2014
Prostatic capsule‐ and seminal‐sparing cystectomy for bladder carcinoma: initial results for selected patients
2004
Urethral Recurrence of Transitional Cell Carcinoma of the Bladder
1998
Electrovaporization of the Prostate with the Gyrus Device
2001
Short-term prophylaxis with cefotaxime in prostatic surgery
1984
Correlation of delayed hypersensitivity and leukocyte migration inhibition factor in the serum of cancer patients
1977
Results of an Epidemiological Survey Using a Modified American Urological Association Symptom Index for Benign Prostatic Hyperplasia in France
1994
Impact of Symptoms of Prostatism on Level of Bother and Quality of Life of Men in the French Community
1995
Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo.
1987
Serum migration inhibitory activity in patients with infectious diseases and various neoplasia
1977
RECURRENCE, PROGRESSION AND SUCCESS IN STAGE TA GRADE 3 BLADDER TUMORS TREATED WITH LOW DOSE BACILLUS CALMETTE-GUERIN INSTILLATIONS
2000
Percutaneous Core Biopsy for Renal Masses: Indications, Accuracy and Results
2007
CORRELATION BETWEEN p53 OVER EXPRESSION AND RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY IN A HIGH RISK SELECT POPULATION OF PATIENTS WITH T1G3 BLADDER CANCER
1998
Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer.
1998
TADALAFIL EXERTS AN ADDITIVE EFFECT ON ALFUZOSIN- INDUCED RELAXATION IN PRE-CONTRACTED HUMAN ISOLATED PROSTATIC ADENOMA
2008